These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5310945)

  • 1. Demonstration in tissue culture of myelinotoxicity in cerebrospinal fluid and brain extracts from multiple sclerosis patients.
    Kim SU; Murray MR; Tourtellotte WW; Parker JA
    J Neuropathol Exp Neurol; 1970 Jul; 29(3):420-31. PubMed ID: 5310945
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifocal areas of synthesis of immunoglobulin-G in multiple sclerosis brain tissue and the sink action of the cerebrospinal fluid.
    Tourtellotte WW; Itabashi HH; Parker JA
    Trans Am Neurol Assoc; 1967; 92():288-90. PubMed ID: 5634066
    [No Abstract]   [Full Text] [Related]  

  • 3. [Etiopathogenesis of multiple sclerosis in the light of current studies].
    Strelau K
    Neurol Neurochir Pol; 1972; 6(1):93-8. PubMed ID: 4553032
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune reactivity now the focus of research on multiple sclerosis.
    Check W
    JAMA; 1978 Jul; 240(1):9-11, 14. PubMed ID: 660816
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating demyelinating factors in acute idiopathic polyneuropathy.
    Cook SD; Dowling PC; Murray MR; Whitaker JN
    Arch Neurol; 1971 Feb; 24(2):136-44. PubMed ID: 5540378
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration.
    Lisak RP; Zwiman B; Norman M
    Arch Neurol; 1975 Mar; 32(3):163-7. PubMed ID: 804300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
    Blauth K; Soltys J; Matschulat A; Reiter CR; Ritchie A; Baird NL; Bennett JL; Owens GP
    Acta Neuropathol; 2015 Dec; 130(6):765-81. PubMed ID: 26511623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synthesis of IgG by cells from the cerebrospinal fluid in a patient with multiple sclerosis.
    Sandberg-Wollheim M; Zettervall O; Müller R
    Clin Exp Immunol; 1969 Apr; 4(4):401-5. PubMed ID: 5787339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental allergic encephalomyelitis: demyelinating activity of serum and sensitized lymph node cells on cultured nerve tissues.
    Bornstein MB; Iwanami H
    J Neuropathol Exp Neurol; 1971 Apr; 30(2):240-8. PubMed ID: 5147780
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
    Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
    J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: serum gamma globulin and demyelination in organ culture.
    Grundke-Iqbal I; Bornstein MB
    Neurology; 1980 Jul; 30(7 Pt 1):749-54. PubMed ID: 6156428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demyelination in in vitro culture in multiple sclerosis: facts and controversies].
    Hauw JJ; de Brunier O; Boutry JM; Schuller E; Lyon-Caen O
    Pathol Biol (Paris); 1987 Mar; 35(3):319-24. PubMed ID: 3295698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
    Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
    Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome.
    Ferraro D; Simone AM; Bedin R; Galli V; Vitetta F; Federzoni L; D'Amico R; Merelli E; Nichelli PF; Sola P
    J Neuroimmunol; 2013 Apr; 257(1-2):76-81. PubMed ID: 23434160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.
    Lisak RP; Zweiman B
    N Engl J Med; 1977 Oct; 297(16):850-3. PubMed ID: 904660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demyelination and autoimmunity].
    Lebar R
    Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement fixation reactions with extracts from demyelinating foci and with other lipid posessing antigens in multiple sclerosis. Critical studies including clincal control groups].
    Roemer GB; Mai K
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):370-90. PubMed ID: 4233550
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebrospinal fluid in multiple sclerosis. Its diagnostic value under immunologic aspects].
    Delank HW
    Fortschr Neurol Psychiatr Grenzgeb; 1972 Aug; 40(8):440-53. PubMed ID: 4484562
    [No Abstract]   [Full Text] [Related]  

  • 19. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosis.
    Cid C; Alvarez-Cermeño JC; Camafeita E; Salinas M; Alcázar A
    FASEB J; 2004 Feb; 18(2):409-11. PubMed ID: 14688203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.